U.S. market Closed. Opens in 1 day 10 hours 14 minutes

MLEC | Moolec Science SA Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.8500 - 0.8637
52 Week Range 0.7500 - 3.25
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 10,482
Average Volume 24,771
Shares Outstanding 38,470,700
Market Cap 32,700,095
Sector Healthcare
Industry Biotechnology
IPO Date 2021-03-02
Valuation
Profitability
Growth
Health
P/E Ratio -4.47
Forward P/E Ratio N/A
EPS -0.19
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 52
Country Luxembourg
Website MLEC
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
*Chart delayed
Analyzing fundamentals for MLEC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see MLEC Fundamentals page.

Watching at MLEC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on MLEC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙